Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 15/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

100%

3 of 3 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A
3(75.0%)
Phase 4
1(25.0%)
4Total
N/A(3)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT01285024Not ApplicableCompleted

A Prospective Study to Evaluate the Effectiveness of a Haemostatic Agent in Primary Unilateral Total Hip Arthroplasty

Role: collaborator

NCT00147823Not ApplicableCompleted

Comparing Synthetic Bone Alone Versus Synthetic Bone With Bone Marrow in Bone Lesions

Role: collaborator

NCT02165943Unknown

Evaluation of Vitoss With and Without BMA for Benign Cavitary Lesions

Role: lead

NCT01027286Phase 4Completed

Prospective Evaluation of Vitagel for Reduction in Blood Loss and Pain Following Unilateral Total Knee Arthroplasty

Role: collaborator

NCT00290862Not ApplicableUnknown

A Safety and Efficacy Study for Treatment of Painful Vertebral Compression Fractures Caused by Osteoporosis

Role: lead

All 5 trials loaded